Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial

Joanna E. Rimmer, Clayton Harro, David A. Sack, Kawsar R. Talaat, Ramiro L. Gutierrez, Barbara DeNearing, Jessica Brubaker, Renee M. Laird, Frédéric Poly, Alexander C. Maue, Kayla Jaep, Ashley Alcala, Yelizaveta Mochalova, Christina L. Gariepy, Subhra Chakraborty, Patricia Guerry, David R. Tribble, Chad K. Porter, Mark S. Riddle